Medtronic Minimed, Inc.
Clinical trials sponsored by Medtronic Minimed, Inc., explained in plain language.
-
New insulin pump aims to improve blood sugar control in type 1 diabetes
Disease control Not yet recruitingThis study will test a new experimental insulin delivery system (NMX8) in 230 adults with type 1 diabetes who are not meeting their blood sugar goals with current automated insulin pumps. The goal is to see if the NMX8 system is safe and helps keep blood sugar in a healthy range …
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated May 26, 2026 04:56 UTC
-
New insulin pump system aims to improve diabetes management
Disease control Not yet recruitingThis study will test a new experimental insulin delivery system (NMX8) in 116 people with type 1 or type 2 diabetes who need insulin. The goal is to see if the new system is safe and works as well as the current Medtronic 780G system at keeping blood sugar in a healthy range. Par…
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC